The Form 4 filing, a report of insider stock activity, was filed on October 13, 2026. The sale took place one day earlier, on October 12. It lists LIU GENE as chief accounting officer of Atlassian Corp (TEAM).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 337 |
| Price | $210.00 |
| Total Transaction Value | $70,770.00 |
| Insider | |
| Ticker Symbol | TEAM |
| Company | Atlassian Corp |
| Insider Name | LIU GENE |
| Insider Title | Chief Accounting Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 55,531 |
| Position Size Change | 0.60% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of 337 TEAM shares in one transaction. It was reported with transaction code S, which identifies a stock sale.
What was the average price of the transaction?
The average sale price was $210.00 per share.
How did this transaction affect the insider's holdings?
The sale reduced the reported holdings by 337 shares, leaving 55,531 shares owned afterward. The shares sold made up 0.60% of the shares owned before the sale.
What's the total transaction value?
The total transaction value was $70,770.00 for the one reported sale.
Are there any special circumstances around this transaction?
A Rule 10b5-1 trading-plan reference was identified for this filing. These plans set trading instructions in advance. The available details do not show whether the reference applies to this sale specifically or to the filing as a whole. Footnote text and plan terms are unavailable, so the sale’s coverage under a plan cannot be confirmed. The plan’s start date and trading schedule are also unknown.
For research purposes only; not investment advice.